Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 265-3, pseudogene (LINC00265-3P)
- Target
- LINC00265-3P
- Molecular classification
- Other (Long non-coding RNA, pseudogene), Not classified as receptor, enzyme, transporter, transcription factor, ion channel, or other typical drug target classes
01
Overview
Long intergenic non-protein coding RNA 265-3, pseudogene (LINC00265-3P) is a non-coding RNA classified as a pseudogene, meaning it does not encode functional protein and is not known to produce an active RNA transcript with biological activity[3]. Most biomedical research and clinical interest focus on the functional transcript LINC00265, which is a long non-coding RNA associated with cell proliferation, migration, invasion, and cancer biology in several tumor types[1][2][4][5]. There is currently no evidence that the pseudogene variant LINC00265-3P has therapeutic, biological, or disease relevance.
- Other names
- NCRNA00265-3PNCRNA00265C
02
Mechanism of action
No mechanisms reported for drugs targeting LINC00265-3P or LINC00265 (there are currently no direct pharmacological modulators).
03
Biological functions
No well-documented biological functions for LINC00265-3P (pseudogene) variant itself.
04
Disease associations
No validated disease roles for LINC00265-3P pseudogene.
05
Safety considerations
None described, as there are no targeted drugs or clinical interventions related to LINC00265-3P pseudogene.
06
Interacting drugs
None identified for LINC00265-3P pseudogene or for LINC00265. No known drugs or small molecules reported to target this RNA.
07
Biomarkers
No established biomarker indications for LINC00265-3P pseudogene.
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 265-3, pseudogene (LINC00265-3P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 265-3, pseudogene (LINC00265-3P).